Page last updated: 2024-09-05

sorafenib and beta-escin

sorafenib has been researched along with beta-escin in 2 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(beta-escin)
Trials
(beta-escin)
Recent Studies (post-2010) (beta-escin)
6,5207305,25114,1372116,278

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brandt, R; Dredge, K; Hammond, E1
Dong, H; Gao, W; Ma, L; Man, S; Yang, L; Yao, J1

Other Studies

2 other study(ies) available for sorafenib and beta-escin

ArticleYear
PG545, a heparan sulfate mimetic, reduces heparanase expression in vivo, blocks spontaneous metastases and enhances overall survival in the 4T1 breast carcinoma model.
    PloS one, 2012, Volume: 7, Issue:12

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cells, Cultured; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Glucuronidase; Human Umbilical Vein Endothelial Cells; Humans; Immunoenzyme Techniques; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Neovascularization, Pathologic; Niacinamide; Phenylurea Compounds; Saponins; Sorafenib

2012
Combinatorial treatment of Rhizoma Paridis saponins and sorafenib overcomes the intolerance of sorafenib.
    The Journal of steroid biochemistry and molecular biology, 2018, Volume: 183

    Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Drug Resistance, Neoplasm; Drug Therapy, Combination; Female; Humans; Liver Neoplasms; Metabolomics; Mice; Rhizome; Saponins; Signal Transduction; Sorafenib; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2018